NeoGraph Analytics
Medical DevicesWestern Europe2023 – 2032

Global Europe Wearable Medical Devices Market Analysis, Opportunities and Forecast 2024-2032

Europe wearable medical devices market valued at USD 12.5B in 2023, forecasted to reach USD 36.1B by 2032 at 12.5% CAGR.

Revenue, 2023

$12.5B

Forecast, 2032

$36.1B

CAGR, 2024-2032

12.5%

Report Coverage

Western Europe

Code: europe-wearable-medical-devices-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The European wearable medical devices market was valued at USD 12.5 billion in 2023 and is projected to reach USD 36.1 billion by 2032, growing at a CAGR of 12.5%. Key growth drivers include rising chronic disease prevalence, aging populations, expanding remote patient monitoring reimbursement, and increasing consumer health awareness. Germany, the United Kingdom, and France lead regional adoption. Continuous glucose monitors and cardiac monitoring devices represent the fastest-growing segments. Medtronic, Koninklijke Philips, and Abbott Laboratories are the dominant players. Regulatory harmonization under EU MDR and digital health strategies across member states further accelerate market expansion.

02

Key Highlights

1

Europe's wearable medical device market reaches USD 36.1B by 2032, growing at 12.5% CAGR from USD 12.5B base.

2

CGM and cardiac monitoring devices lead segment growth, driven by diabetes and cardiovascular disease prevalence.

3

Germany, UK, and France account for 59% of regional revenue, with Eastern Europe emerging as high-growth frontier.

03

Market Overview

Market Context

Europe represents approximately 30% of the global wearable medical devices market, driven by robust healthcare infrastructure, favorable reimbursement policies, and high digital health adoption. The region's aging population and rising chronic disease burden fuel demand for continuous monitoring solutions. EU regulatory frameworks and cross-border digital health initiatives create a supportive environment for market growth.

Europe accounts for approximately 30% of the global wearable medical devices market, with strong demand driven by chronic disease management and aging demographics. The region benefits from robust healthcare infrastructure and favorable EU digital health policies. Adoption is transitioning from hospital-centric to home-based monitoring.

Market Stage

High growth

Adoption Level

Growing

Key Trends

AI-powered predictive analytics integrated into wearable health monitorsExpansion of CGM technology beyond diabetes into metabolic health monitoringEU MDR compliance reshaping product development and market entry strategiesGrowing convergence of consumer wearables and clinical-grade medical devicesCross-border telehealth interoperability initiatives across EU member states
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 12.5%

Base Year (2023)

$12.5B

Forecast (2032)

$36.1B

CAGR (2024-2032)

12.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$12.50B
2024$14.06B
2025$15.82B
2026$17.80B
2027$20.02B
2028$22.53B
2029$25.34B
2030$28.51B
2031$32.07B
2032$36.08B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The European wearable medical devices market is expected to grow from USD 12.5 billion in 2023 to USD 36.1 billion by 2032 at a 12.5% CAGR. Western Europe dominates with 42% share, while Eastern Europe shows the highest growth potential. Cardiac monitoring and CGM segments will drive incremental revenue. Post-pandemic telehealth adoption sustains RPM demand across the region.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
Western Europe42.0%11.8%Germany
Northern Europe28.0%13.2%United Kingdom
Southern Europe18.0%12.1%France
Eastern Europe12.0%14.5%Poland

Western Europe

#1
Share: 42.0%CAGR: 11.8%

Largest market: Germany

Northern Europe

#2
Share: 28.0%CAGR: 13.2%

Largest market: United Kingdom

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Rising chronic disease prevalence and aging European population increase demand for continuous health monitoring.
  • Expanded EU reimbursement codes accelerate remote patient monitoring adoption across healthcare facilities.
  • Growing consumer health awareness and fitness tracking adoption drive wearable medical device purchases.
06

Market Segmentation

By Application
Market share distribution across 5 segments
By Application — market share by segment, in percent.
SegmentShare
Remote Patient MonitoringLargest application segment driven by post-pandemic telehealth adoption and expanding EU reimbursement policies.38.0%
Chronic Disease ManagementDiabetes, cardiovascular, and respiratory disease management represent primary use cases for wearable medical devices.28.0%
Fitness & Wellness MonitoringConsumer health tracking drives volume adoption, with increasing crossover into preventive healthcare applications.18.0%
Post-Surgical MonitoringHospitals deploy wearable devices for continuous post-operative monitoring, reducing readmission rates and costs.10.0%
Emergency Alert SystemsFall detection and emergency response wearables serve Europe's growing elderly population segment.6.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
By Product Type
Market share distribution across 6 segments
By Product Type — market share by segment, in percent.
SegmentShare
Smartwatches & Fitness TrackersConsumer-grade devices with clinical features like ECG and SpO2 monitoring dominate volume sales across Europe.35.0%
Continuous Glucose MonitorsCGM adoption surging due to rising diabetes prevalence and expanding insurance reimbursement across EU countries.20.0%
Cardiac Monitoring DevicesHolter monitors and wearable ECG patches see strong demand driven by Europe's aging population and cardiovascular disease burden.18.0%
Pulse Oximeters & Respiratory MonitorsPost-pandemic demand sustains growth in wearable respiratory monitoring devices for home and clinical use.12.0%
Blood Pressure MonitorsWearable cuffless blood pressure monitors gain traction as hypertension management shifts to home-based care.10.0%
Smart Patches & BiosensorsEmerging segment with adhesive biosensor patches for continuous multi-parameter monitoring in hospital and home settings.5.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
07

Regional Analysis

1

Western Europe

Lead: Germany
CAGR: 11.8%Share: 42.0%

Largest market share driven by Germany, France, and Benelux countries with advanced healthcare infrastructure and strong reimbursement frameworks.

2

Northern Europe

Lead: United Kingdom
CAGR: 13.2%Share: 28.0%

High digital health adoption and government-backed remote monitoring programs fuel rapid market expansion across Nordic and UK markets.

3

Southern Europe

Lead: France
CAGR: 12.1%Share: 18.0%

Growing elderly population and chronic disease burden in Italy, Spain, and France drive steady wearable medical device demand.

4

Eastern Europe

Lead: Poland
CAGR: 14.5%Share: 12.0%

Fastest-growing region as healthcare digitization investments and EU funding programs accelerate wearable device adoption.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
Germany
24.0%
+11.5%
United Kingdom
19.0%
+12.8%
France
16.0%
+11.2%
Italy
10.0%
+12.4%
Spain
8.0%
+13.1%
08

Competitive Landscape

M

Medtronic plc

Ireland

Leader31.7B

Dominates Europe's wearable cardiac monitoring and neuromodulation segments with extensive clinical-grade product portfolio.

Global medtech leader headquartered in Ireland with the broadest wearable cardiac monitoring and neuromodulation portfolio in Europe.

K

Koninklijke Philips N.V.

Netherlands

Challenger18.2B

Strong presence in European hospital and home monitoring with FDA-cleared Biosensor BX100 wearable patch platform.

Netherlands-based health technology company providing integrated hospital-to-home wearable monitoring solutions across Europe.

A

Abbott Laboratories

United States

Follower40.1B

Market-leading FreeStyle Libre CGM drives strong European diabetes monitoring segment growth and expanding consumer biowearable line.

US-based medtech giant leading Europe's continuous glucose monitoring market with its FreeStyle Libre system and expanding biowearable portfolio.

09

Recent Developments

25
2025Abbott Laboratories

FreeStyle Libre 3 receives expanded EU reimbursement coverage across 12 additional member states.

25
2025Medtronic plc

Medtronic secures EU MDR Class IIb certification for its latest Guardian Sensor 3 continuous monitoring platform.

24
2024Koninklijke Philips N.V.

Philips launches next-generation Biosensor BX100 with Bluetooth LE connectivity for seamless European hospital integration.

10

Regulatory Landscape

EU Medical Device Regulation (MDR 2017/745) governs clinical-grade wearable device classification and market authorizationGDPR (General Data Protection Regulation) imposes strict requirements on health data collection, processing, and cross-border transferEU Digital Health Strategy and European Health Data Space (EHDS) framework enables cross-border health data interoperabilityCE marking requirements for wearable medical devices entering the European Economic Area market
11

Research Methodology

Primary research

  • Expert interviews with European healthcare providers
  • Surveys of clinical practitioners and device users
  • Stakeholder consultations with EU regulatory bodies

Secondary research

  • Industry analyst reports from Mordor Intelligence and Fortune Business Insights
  • Company financial filings and investor presentations
  • EU Commission digital health publications and reimbursement databases

Validation: Triangulation method combining primary expert insights with secondary data sources and cross-referencing against regulatory filings

12

Strategic Takeaways

Investors

Focus on CGM and cardiac monitoring segments in Germany and UK for highest ROI potential through 2032.

Operators

Leverage EU digital health frameworks and RPM reimbursement expansion to scale wearable device deployments across clinical settings.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.